News

The deadline to get money back as part of a $4.5 million class action settlement involving certain Robitussin products is ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...